Illumina Inc (NAS:ILMN)
$ 114.41 -0.6 (-0.52%) Market Cap: 18.23 Bil Enterprise Value: 19.52 Bil PE Ratio: 0 PB Ratio: 3.17 GF Score: 81/100

Illumina Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 11, 2021 / 07:00PM GMT
Release Date Price: $502.77 (-0.71%)
John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate

So getting started here in the next panel. Happy to be hosting Francis deSouza from Illumina, President and CEO. Hi, Francis.

Francis A. deSouza
Illumina, Inc. - CEO & Director

John, how are you?

John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate

Pretty good.

Questions & Answers

John Newton Sourbeer
UBS Investment Bank, Research Division - Equity Research Associate

So I guess maybe just kind of getting started off with Q3 and '21 guidance the company just reported last week. The company has stated that they're seeing activity in both academic and clinical markets above pre-COVID levels. Can you maybe talk on the outlook for these 2 markets? And how has COVID changed the growth dynamics?

Francis A. deSouza
Illumina, Inc. - CEO & Director

Sure, John. Now let me start with the safe

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot